IDENTIFY INVESTMENT RISKS
A risk-based analysis to support your investment due diligence needs.
If you are looking to invest in a pharmaceutical, biotech or medical device company, product or technology, a sound due diligence process is a must.
PharmaBioSource provides consulting services to the Life Sciences investment community to identify potential investment risks. Our expert opinions on supply chain, regulatory and threats to cash flow can be invaluable to investors during the due diligence process. By identifying potential supply chain risks or confirming the level of robustness, investors can feel comfortable by being aware of potential risks prior to making an investment.
PharmaBioSource will partner with you to analyze and identify risks to support your go-no-go decisions on investments, for use as leverage in negotiations and for risk mitigation planning after an investment.Work With Us
At PharmaBioSource, we use proven due diligence methodologies and techniques combined with real-world experience to challenge investment expectations, no matter how complex.
Through a collaborative team approach, the experts at PharmaBioSource work directly with you every step of the way, from project inception to completion and beyond.
Are critical materials single-sourced? Are contract manufacturers reliable? You can rely on our evaluations to determine if enhancements are necessary to ensure a secure supply chain.
Are there competitive products that may impact revenue projections? Are there cost of goods issues that could impact profits? Are there other factors that could affect market share?
Let our scientific and manufacturing experts evaluate the robustness of a manufacturing process to challenge yields and mitigate supply risks.
Let us conduct a high-level review of the regulatory history of a manufacturing site or contract manufacturer to assess the Quality environment, systems and culture.